Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Wang Xiaodong. Director active across 3 companies, notably BeiGene, Ltd.. Aggregated, 41 filings have been recorded. Split: 0 buy · 11 sells. Total volume traded: €2.7m. History available since 10 May 2021. The latest transaction was disclosed on 7 November 2025 (Don). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Wang Xiaodong
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Wang Xiaodong is a director of BeiGene, Ltd., a director of BeOne Medicines Ltd., and linked to Clover Biopharmaceuticals, Ltd. - B. He has 41 filings in total, and across the recent filings available from 2021-05-12 to 2026-06-25, the activity is sales for EUR 2688800, with the main transaction nature listed as Sale.